Study Testing The Safety and Efficacy of Adjuvant Temozolomide Plus TTFields (Optune®) Plus Pembrolizumab in Patients With Newly Diagnosed Glioblastoma (2-THE-TOP)
Clinical trial NCT03405792 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03405792
- Sponsor
- University of Florida
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-23
- Primary completion
- 2022-11-26
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.